- November 2009
Dr. Moore Joins the Board of Directors of Immunotech
- Dr. Roscoe M. Moore, Jr. has joined the
Board of Directors of Immunotech Laboratories Incorporated of
Glendale, California. Immunotech is a publicly trade company.
It has indefinite licensing rights to the Irreversible Pepsin
Fraction (IPF) peptide molecule for the specific treatment of
HIV/AIDS. IPF has demonstrated to have both fusion inhibitor
and immunomodulator capabilities during in vitro studies with
no viral resistance. This provides potential option opportunities
for patients that have already shown resistance to one or more
antiretroviral (ARV) therapies. Resistance to all commercially
available ARV agents within all classes has been reported. The
Company is seeking fast track status designation from the U.S.
Food and Drug Administration.
- October 2009
Dr. Moore Serves on the Scientific Advisory
Board of Award Winning Company, Telcare
- Telcare, LLC is a privately held Maryland
company founded by Dr. Jonathan Javitt, a physician and former
health advisor to both the Clinton and Bush Administrations.
Telcare won the People’s Choice Award at the CTIA Fund Fest
held in San Diego, California on October 14, 2009. The CTIA
Fund Fest is sponsored by CTIA WIRELESS, the international association
for the wireless telecommunications industry. Telcare uses “machine-2-machine”
cellular technology to link patients with chronic illnesses
(e.g., diabetes) to physicians and other caregivers in order
to improve compliance with treatment and outcomes of care. By
creating an immediate two-way feedback loop between patient
and caregiver, Telcare has already demonstrated the potential
to reduce incidence and costs of complications by nearly 40
percent, at no added cost to the health care system. Dr. Javitt,
Founder and CEO accepted the People’s Choice Award for Telcare.
- September 2009
Dr. Moore Attends Invited Dinner with Delegation
from the Delta State of Nigeria
- On September 3, 2009, The Executive Governor
of The Delta State of Nigeria, the Honorable Doctor Emmanuel
Uduaghan, invited Dr. Roscoe M. Moore, Jr. and about 20 others
to attend a private dinner to explore linkages and partnership
opportunities with this important and critical state in Nigeria.
The Delta State is a major oil producing region of Nigeria.
Dr. Uduaghan is a physician trained in the specialty of anesthesia.
He has served in a number of important and relevant health-related
positions in the Delta State. While serving as Assistant United
States Surgeon General (now retired), Nigeria was one of 53
African countries that Dr. Moore had responsibility for while
serving in the Immediate Office of the U.S. Secretary for Health
and Human Services.
- June 2009
Dr. Moore Recognized by the Greater Silver
Spring Chamber of Commerce
- Dr. Roscoe M. Moore, Jr., President of
PH RockWood Corporation was the recipient of the 2009 Chair’s
Award by the Greater Silver Spring Chamber of Commerce at its
Annual Gala on June 11, 2009. Dr. Moore was recognized for his
prompt financial support of the Chamber’s short term goals and
objectives. He is a member of the Board of Directors of the
Chamber, and his company was recognized in 2007 as a recipient
of the Chamber’s Small Business Award.
- April 2009
Dr Moore Appointed to Scientific Advisory Board of
- On April 28, 2009, the Board of Directors for Tobira
Therapeutics appointed Dr. Roscoe M. Moore, Jr., Assistant United States
Surgeon General (Retired), to its Scientific Advisory Board. Tobira Therapeutics
is a privately held company which is committed to advancing research and
product discovery against life-threatening and life-altering infectious
diseases, such as HIV/AIDS. Tobira Therapeutics is headquartered in Princeton,
- March 2009
Dr. Moore Re-appointed to Maryland Health Care Commission
- On March 20, 2009, the Honorable Martin O’Malley
(Democrat), Governor of Maryland, re-appointed Dr. Roscoe M. Moore, Jr.
to a 4-year term as a Commissioner on the Maryland Health Care Commission.
Dr. Moore’s initial 4-year term as a Commissioner was at the direction
of the former Governor of Maryland, the Honorable Robert Ehrlich (Republican).
Dr. Moore served for 10-years on the Board of Directors of the Montgomery
General Hospital, Olney, Maryland, in a number of positions of leadership.
Montgomery General Hospital is now an integral part of MedStar Health,
a $3.1 billion non-profit healthcare organization. The Maryland Health
Care Commission is a public regulatory commission created to address the
health system needs of the State.
- March 2009
Dr. Moore Joins Scientific Advisory Board of HemoBioTech
- On March 12, 2009, Dr. Roscoe M. Moore, Jr. joined
the Scientific Advisory Board of HemoBioTech, Inc. of Dallas, Texas. HemoBioTech
is engaged in the commercial development of a novel human blood substitute
technology composed of bovine hemoglobin. About 10% of the new cases of
HIV/AIDS globally are caused by HIV contaminated blood. There is a major
need for a safe alternative to human blood. Dr. Moore will work closely
with publicly traded HemoBioTech (HMBT.OB), and its medical researchers,
physicians and scientists to this end. Dr. Moore, Assistant United States
Surgeon General (Retired), has extensive expertise and specific experience
in making the Nation’s and the World’s blood supply systems safer from
the transmission of infectious diseases.